Marinus Pharma CS (MRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 1,547 | 171 | 0 | 0 | 0 |
| Gross Profit | 1,547 | 171 | N/A | N/A | N/A |
| Operating Expenses | 19,049 | 15,870 | 15,882 | 18,854 | 15,472 |
| Operating Income | -17,502 | -15,699 | -15,882 | -18,854 | -15,472 |
| Other Income | 33 | 40 | 207 | 182 | 63 |
| Pre-tax Income | -17,469 | -15,659 | -15,675 | -18,672 | -15,409 |
| Net Income Continuous | -17,469 | -15,659 | -15,675 | -18,672 | -15,409 |
| Net Income | $-17,469 | $-15,659 | $-15,675 | $-18,672 | $-15,409 |
| EPS Basic Total Ops | -0.39 | -0.51 | -0.63 | -1.27 | -1.00 |
| EPS Basic Continuous Ops | -0.47 | -0.51 | -0.63 | -0.86 | -1.02 |
| EPS Diluted Total Ops | -0.39 | -0.51 | -0.63 | -1.27 | -1.00 |
| EPS Diluted Continuous Ops | -0.47 | -0.51 | -0.63 | -0.86 | -1.02 |
| EBITDA(a) | $-17,408 | $-15,625 | $-15,798 | $-18,769 | $-15,392 |